Evidence map›Paper›PMID 20858604›Full record

ArticleHuman molecular genetics2010

Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease.

Marian C Aldhous, Suhaili Abu Bakar, Natalie J Prescott, Raquel Palla, Kimberley Soo, John C Mansfield, Christopher G Mathew, Jack Satsangi, John A L Armour

Abstract read
In one paragraph

Article in Human molecular genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Copy Number of theApplied and environmental microbiology · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Human β-Defensin 2 in Primary Sclerosing Cholangitis.Clinical and translational gastroenterology · 2017
    Article
  13. Article
  14. Duplication of chicken defensin7 gene generated by gene conversion and homologous recombination.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marian C AldhousGastrointestinal Unit, School of Clinical and Molecular Medicine, Western General Hospital, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, Scotland, UK.
Suhaili Abu Bakar
Natalie J Prescott
Raquel Palla
Kimberley Soo
John C Mansfield
Christopher G Mathew
Jack Satsangi
John A L Armour

Funding

Chief Scientist Office CZB/4/540Chief Scientist Office CZB/4/638Medical Research Council G0600329Medical Research Council G0800675Medical Research Council G0800759Wellcome Trust 081808
6 · The paper itself

Abstract

The copy number variation in beta-defensin genes on human chromosome 8 has been proposed to underlie susceptibility to inflammatory disorders, but presents considerable challenges for accurate typing on the scale required for adequately powered case-control studies. In this work, we have used accurate methods of copy number typing based on the paralogue ratio test (PRT) to assess beta-defensin copy number in more than 1500 UK DNA samples including more than 1000 cases of Crohn's disease. A subset of 625 samples was typed using both PRT-based methods and standard real-time PCR methods, from which direct comparisons highlight potentially serious shortcomings of a real-time PCR assay for typing this variant. Comparing our PRT-based results with two previous studies based only on real-time PCR, we find no evidence to support the reported association of Crohn's disease with either low or high beta-defensin copy number; furthermore, it is noteworthy that there are disagreements between different studies on the observed frequency distribution of copy number states among European controls. We suggest safeguards to be adopted in assessing and reporting the accuracy of copy number measurement, with particular emphasis on integer clustering of results, to avoid reporting of spurious associations in future case-control studies.

Indexed as

Genetic Predisposition to Diseasebeta-DefensinsCase-Control StudiesCrohn DiseaseDNA Copy Number VariationsGenetic Association StudiesGenome, HumanHumansLondonReproducibility of ResultsReverse Transcriptase Polymerase Chain ReactionScotlandSequence Homology, Nucleic Acidbeta-Defensins

Identifiers

PMID20858604
PMCPMC2989891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.